Ondine

Ondine Biomedical is a company headquartered in Canada. Ondine has developed a patented photodisinfection technology platform for the treatment and prevention of a broad-spectrum of pathogens—including multidrug-resistant strains. Ondine Biomedical focuses on the development and commercialization of novel antimicrobial therapies to address significant patient needs. The company’s lead product, Steriwave™, is a light-based disinfection medical device designed to eliminate harmful nasal pathogens that may cause hospital-acquired infections (HAIs). Steriwave has been deployed in Canadian hospitals for many years and has significantly reduced infection rates.